NOVYRA PHARMACHEM, a company in the Tea & Coffee industry, reported revenue of ₹4.23 crore and a net loss of ₹0.03 crore for the September 2026 quarter.
NOVYRA PHARMACHEM (BSE: NOVYRA) closed at ₹8.88 on 20 Nov 2026, down 15.3% over the past year. Its market capitalisation is ₹6 crore.
Incorporated in 1987, Bansisons Tea Industries Ltd produces tea, and leases tea garden
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.